The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A dual tyrosine kinase inhibitor lapatinib and overexpression of matrix metallopeptidase 1 (MMP1) in endometrial cancer.
Chyong-Huey Lai
No relevant relationships to disclose
Chiao-Yun Lin
No relevant relationships to disclose
Angel Chao
No relevant relationships to disclose
Tzu-Hao Wang
No relevant relationships to disclose
Huei-Jean Huang
No relevant relationships to disclose